CALL FOR PAPERS

Author Information

CERTIFICATE

IMPACT FACTOR 2021

Subject Area

Life Sciences / Biology
Architecture / Building Management
Asian Studies
Business & Management
Chemistry
Computer Science
Economics & Finance
Engineering / Acoustics
Environmental Science
Agricultural Sciences
Pharmaceutical Sciences
General Sciences
Materials Science
Mathematics
Medicine
Nanotechnology & Nanoscience
Nonlinear Science
Chaos & Dynamical Systems
Physics
Social Sciences & Humanities

Why Us? >>

Open Access
Peer Reviewed
Rapid Publication
Life time hosting
Free promotion service
Free indexing service
More citations
Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Evaluation of therapeutic recombinant follicle stimulating hormone batches for their identity and potency before use in patients

Author:

Richa Baranwal, Rashmi Srivastava, Nanda Gopal, Subhash Kumar, Rajeev Srivastava, Mohit Kumar, Aditi Saini, Rashmi Jain, Niharika Sood, Charu M Kamal, Prasad, J. P. and Shikha Yadav

Subject Area:

Life Sciences

Abstract:

Follicle stimulating hormone (FSH) is a gonadotropic hormone produced by the anterior lobe of the mammalian pituitary gland which regulates the normal female and male gamete growth and maturation and normal gonadal steroid production. Deficient endogenous production of FSH is a known cause of infertility and therapeutic preparations of FSH are widely used in the treatment of this condition. In this study, 27 batches of therapeutic rh-FSH preparations were evaluated for their identity and potency before the batch release for use in patients, by using rat ovary weight gain assay as described in the European Pharmacopoeia. The results were calculated by using the Parallel-line assay; COMBISTATS v 4.0 software from EDQM. Based on the findings, it was established that all the 27 batches of rh-FSH were identified to be Follicle Stimulating Hormone and their estimated potencies were found to be within the specification limits as per the European Pharmacopeia.

PDF file: